Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Qualigen Therapeutics ROE 2015-2024 | QLGN

Current and historical return on equity (ROE) values for Qualigen Therapeutics (QLGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Qualigen Therapeutics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.01B $0.00B 266.67%
2024-06-30 $-0.01B $0.00B 333.33%
2024-03-31 $-0.01B $0.00B 880.00%
2023-12-31 $-0.01B $0.00B -1040.00%
2023-09-30 $-0.02B $0.00B -425.00%
2023-06-30 $-0.02B $0.00B -200.00%
2023-03-31 $-0.02B $0.01B -146.94%
2022-12-31 $-0.02B $0.01B -126.32%
2022-09-30 $-0.02B $0.02B -98.46%
2022-06-30 $-0.02B $0.02B -100.00%
2022-03-31 $-0.02B $0.01B -118.52%
2021-12-31 $-0.02B $0.02B -121.43%
2021-06-30 $-0.02B $0.01B -167.44%
2021-03-31 $-0.03B $0.02B -711.11%
2020-09-30 $-0.03B $0.00B 752.94%
2020-06-30 $-0.02B $-0.01B 685.71%
2020-03-31 $-0.01B $0.00B -2400.00%
2019-12-31 $-0.01B $0.00B -500.00%
2019-09-30 $-0.02B $0.00B -375.00%
2019-06-30 $-0.02B $0.00B -307.69%
2019-03-31 $-0.02B $0.01B -235.90%
2018-12-31 $-0.02B $0.01B -153.85%
2018-09-30 $-0.02B $0.01B -101.59%
2018-06-30 $-0.01B $0.02B -96.30%
2018-03-31 $-0.01B $0.02B -104.76%
2017-12-31 $-0.01B $0.02B -162.96%
2017-09-30 $-0.01B $0.00B -509.09%
2017-06-30 $-0.02B $0.00B -426.67%
2017-03-31 $-0.02B $0.00B -600.00%
2016-12-31 $-0.02B $0.00B -844.44%
2016-06-30 $-0.01B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.005B
Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.384B 33.53
Zoetis (ZTS) United States $75.427B 28.14
Daiichi Sankyo, - (DSNKY) Japan $51.906B 26.41
Takeda Pharmaceutical (TAK) Japan $47.983B 9.54
Sandoz Group AG (SDZNY) Switzerland $22.594B 0.00
Merck (MKKGY) Germany $17.021B 12.47
United Therapeutics (UTHR) United States $14.681B 12.99
Shionogi (SGIOY) Japan $14.275B 14.30
Summit Therapeutics (SMMT) United States $13.164B 0.00
Neurocrine Biosciences (NBIX) United States $12.327B 42.22
IPSEN (IPSEY) France $10.095B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $7.601B 61.79
Stevanato Group S.p.A (STVN) Italy $6.638B 40.59
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.054B 0.00
Grifols, S.A (GRFS) Spain $5.707B 0.00
Ionis Pharmaceuticals (IONS) United States $5.429B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.813B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.037B 10.64
Crinetics Pharmaceuticals (CRNX) United States $2.985B 0.00
Hypermarcas (HYPMY) Brazil $2.724B 17.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
BioCryst Pharmaceuticals (BCRX) United States $2.245B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.791B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.776B 0.00
Indivior (INDV) United States $1.718B 7.29
Dyne Therapeutics (DYN) United States $1.444B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 0.00
Evotec AG (EVO) Germany $1.413B 0.00
Guardian Pharmacy Services (GRDN) United States $1.347B 0.00
Ocular Therapeutix (OCUL) United States $1.292B 0.00
Harrow (HROW) United States $1.100B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.075B 21.51
Collegium Pharmaceutical (COLL) United States $0.942B 5.08
Enliven Therapeutics (ELVN) United States $0.939B 0.00
Ardelyx (ARDX) United States $0.921B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.918B 0.00
Akebia Therapeutics (AKBA) United States $0.854B 0.00
Xeris Biopharma Holdings (XERS) United States $0.790B 0.00
Cronos Group (CRON) Canada $0.740B 0.00
AleAnna (ANNA) United States $0.647B 0.00
KalVista Pharmaceuticals (KALV) United States $0.642B 0.00
Xencor (XNCR) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.571B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.558B 0.00
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Relay Therapeutics (RLAY) United States $0.545B 0.00
USANA Health Sciences (USNA) United States $0.544B 11.83
Bioventus (BVS) United States $0.529B 13.42
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.441B 0.00
Tourmaline Bio (TRML) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Altimmune (ALT) United States $0.430B 0.00
Verve Therapeutics (VERV) United States $0.427B 0.00
Savara (SVRA) United States $0.415B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.73
Organogenesis (ORGO) United States $0.337B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.279B 0.00
Nature's Sunshine Products (NATR) United States $0.258B 23.80
MediWound (MDWD) Israel $0.240B 0.00
ProKidney (PROK) United States $0.218B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
Esperion Therapeutics (ESPR) United States $0.182B 0.00
Journey Medical (DERM) United States $0.182B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
OmniAb (OABI) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.165B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Inhibikase Therapeutics (IKT) United States $0.152B 0.00
Nektar Therapeutics (NKTR) United States $0.148B 0.00
Larimar Therapeutics (LRMR) United States $0.141B 0.00
Liminatus Pharma (LIMN) $0.140B 0.00
Achieve Life Sciences (ACHV) Canada $0.135B 0.00
Wellgistics Health (WGRX) United States $0.135B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.134B 0.00
Protara Therapeutics (TARA) United States $0.127B 0.00
Aldeyra Therapeutics (ALDX) United States $0.127B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Korro Bio (KRRO) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 63.44
Galectin Therapeutics (GALT) United States $0.082B 0.00
Unicycive Therapeutics (UNCY) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.079B 13.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Surrozen (SRZN) United States $0.070B 0.00
Metagenomi (MGX) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.050B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Lyra Therapeutics (LYRA) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
DURECT (DRRX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00